-
1دورية أكاديمية
المؤلفون: Juric, Dejan, Janku, Filip, Rodón, Jordi, Burris, Howard A., Mayer, Ingrid A., Schuler, Martin, Seggewiss-Bernhardt, Ruth, Gil-Martin, Marta, Middleton, Mark R., Baselga, José, Bootle, Douglas, Demanse, David, Blumenstein, Lars, Schumacher, Karl, Huang, Alan, Quadt, Cornelia, Rugo, Hope S.
المصدر: JAMA Oncology ; volume 5, issue 2, page e184475 ; ISSN 2374-2437
الإتاحة: https://doi.org/10.1001/jamaoncol.2018.4475Test
http:///jamaoncology/article-pdf/5/2/e184475/17295232/jamaoncology_juric_2018_oi_180085.pdfTest -
2دورية أكاديمية
المؤلفون: Neoptolemos, John P., Moore, Malcolm J., Cox, Trevor F., Valle, Juan W., Palmer, Daniel H., McDonald, Alexander C., Carter, Ross, Tebbutt, Niall C., Dervenis, Christos, Smith, David, Glimelius, Bengt, Charnley, Richard M., Lacaine, François, Scarfe, Andrew G., Middleton, Mark R., Anthoney, Alan, Ghaneh, Paula, Halloran, Christopher M., Lerch, Markus M., Oláh, Attila, Rawcliffe, Charlotte L., Verbeke, Caroline S., Campbell, Fiona, Büchler, Markus W., European Study Group for Pancreatic Cancer, for the
المصدر: JAMA ; volume 308, issue 2, page 147 ; ISSN 0098-7484
الإتاحة: https://doi.org/10.1001/jama.2012.7352Test
http://jamanetwork.com/journals/jama/fullarticle/1216477Test -
3دورية أكاديمية
المؤلفون: Lowndes, Sarah A., Asher, Ruth, Middleton, Mark R.
المصدر: Archives of Dermatology ; volume 146, issue 11 ; ISSN 0003-987X
الإتاحة: https://doi.org/10.1001/archdermatol.2010.306Test
http://jamanetwork.com/journals/jamadermatology/fullarticle/422203Test -
4دورية أكاديمية
المؤلفون: Juric, Dejan, Janku, Filip, Rodon, Jordi, Burris, Howard A., Mayer, Ingrid A., Schuler, Martin, Seggewiss-Bernhard, Ruth, Gil-Martin, Marta, Middleton, Mark R., Baselga, Jose, Bootle, Douglas, Demanse, David, Blumenstein, Lars, Schumacher, Karl, Huang, Alan, Quadt, Cornelia, Rugo, Hope S.
العلاقة: Juric, Dejan, Janku, Filip, Rodon, Jordi, Burris, Howard A., Mayer, Ingrid A., Schuler, Martin, Seggewiss-Bernhard, Ruth, Gil-Martin, Marta, Middleton, Mark R., Baselga, Jose, Bootle, Douglas, Demanse, David, Blumenstein, Lars, Schumacher, Karl, Huang, Alan, Quadt, Cornelia and Rugo, Hope S. (2018) Alpelisib (BYL719) plus Fulvestrant in PIK3CA-altered and PIK3CA wild-type ER+ advanced breast cancer. An open-label, phase 1b dose-escalation and expansion study. JAMA oncology, Oncol. E1-E9. ISSN 2374-2437
